AU708049B2 - Method of improving skin condition - Google Patents

Method of improving skin condition Download PDF

Info

Publication number
AU708049B2
AU708049B2 AU30028/97A AU3002897A AU708049B2 AU 708049 B2 AU708049 B2 AU 708049B2 AU 30028/97 A AU30028/97 A AU 30028/97A AU 3002897 A AU3002897 A AU 3002897A AU 708049 B2 AU708049 B2 AU 708049B2
Authority
AU
Australia
Prior art keywords
substrate
wekroma
skin
potential field
magnetic vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU30028/97A
Other languages
English (en)
Other versions
AU3002897A (en
Inventor
Gheorghe Cioca
Joseph Gubernick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EL Management LLC
Original Assignee
EL Management LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EL Management LLC filed Critical EL Management LLC
Publication of AU3002897A publication Critical patent/AU3002897A/en
Application granted granted Critical
Publication of AU708049B2 publication Critical patent/AU708049B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/83—Electrophoresis; Electrodes; Electrolytic phenomena
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/87—Application Devices; Containers; Packaging

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
  • Fats And Perfumes (AREA)
  • Lasers (AREA)
AU30028/97A 1996-05-21 1997-05-13 Method of improving skin condition Ceased AU708049B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/646798 1996-05-21
US08/646,798 US5905265A (en) 1996-05-21 1996-05-21 Method of improving skin condition
PCT/US1997/007936 WO1997044810A1 (en) 1996-05-21 1997-05-13 Method of improving skin condition

Publications (2)

Publication Number Publication Date
AU3002897A AU3002897A (en) 1997-12-09
AU708049B2 true AU708049B2 (en) 1999-07-29

Family

ID=24594498

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30028/97A Ceased AU708049B2 (en) 1996-05-21 1997-05-13 Method of improving skin condition

Country Status (13)

Country Link
US (1) US5905265A (instruction)
JP (1) JP2001508761A (instruction)
KR (1) KR100450713B1 (instruction)
CN (1) CN1123050C (instruction)
AR (1) AR048562A1 (instruction)
AU (1) AU708049B2 (instruction)
CA (1) CA2256348C (instruction)
CO (1) CO4850561A1 (instruction)
IL (1) IL127182A0 (instruction)
IN (1) IN183686B (instruction)
TW (2) TW483020B (instruction)
WO (1) WO1997044810A1 (instruction)
ZA (1) ZA974421B (instruction)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5152999A (en) 1998-07-27 2000-02-21 John Nikolaj Hvarre Device and preparation for the treatment of tap water and drinking water
US6290993B1 (en) * 1999-07-23 2001-09-18 E-L Management Corp. Compositions containing mimosa phenolic compounds
JP2003137807A (ja) * 2001-11-01 2003-05-14 Miyagi Kagaku Kogyo Kk コラーゲン産生促進剤、それを含む化粧品、食品および医薬品ならびに皮膚疾患の予防または改善用外用剤
DE10223221A1 (de) * 2002-05-24 2003-12-11 Sebapharma Gmbh & Co Kg Kosmetische Zusammensetzung mit hautentquellender Wirkung
JP2004167467A (ja) * 2002-11-15 2004-06-17 Lidic Inc 振動情報記録水
GR1004816B (el) * 2003-05-07 2005-02-18 Evalion Ανωνυμη Εταιρεια Παροχης Υπηρεσιων-Συμβουλευτικη-Εμπορικη Μεθοδος μεταφορας συχνοτητων σε ουσιες μεσω κρυσταλλων και παρασκευη σκευασματων τα οποια περιεχουν τις συχνοτητες αυτες
JP2004337831A (ja) * 2003-05-16 2004-12-02 Lidic Inc 生体の生命力を支援する振動情報の生成方法
JP4916143B2 (ja) * 2005-08-04 2012-04-11 サッポロビール株式会社 ビール酵母で発酵させたアルコール飲料からコラーゲン産生促進作用を有する組成物を製造する方法及びその組成物
US20100181261A1 (en) * 2009-01-22 2010-07-22 Eagle Research LLC Aqueous environment treatment apparatus and method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5012110A (en) * 1986-04-11 1991-04-30 Kropp Werner Substrate and process and apparatus for the production therefor
US5247179A (en) * 1990-10-18 1993-09-21 Hiroshi Tachibana Activation energy providing device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0538361A4 (en) * 1990-07-06 1993-05-19 Iit Research Institute Method and apparatus for rendering medical materials safe

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5012110A (en) * 1986-04-11 1991-04-30 Kropp Werner Substrate and process and apparatus for the production therefor
US5138172A (en) * 1986-04-11 1992-08-11 Kropp Werner Apparatus and method for applying information energy to a substrate
US5247179A (en) * 1990-10-18 1993-09-21 Hiroshi Tachibana Activation energy providing device

Also Published As

Publication number Publication date
AR048562A1 (es) 2006-05-10
CO4850561A1 (es) 1999-10-26
TWI272635B (en) 2007-02-01
IN183686B (instruction) 2000-03-18
US5905265A (en) 1999-05-18
ZA974421B (en) 1997-12-22
AU3002897A (en) 1997-12-09
CN1123050C (zh) 2003-10-01
CA2256348A1 (en) 1997-11-27
TW483020B (en) 2002-04-11
IL127182A0 (en) 1999-09-22
JP2001508761A (ja) 2001-07-03
KR20000011142A (ko) 2000-02-25
WO1997044810A1 (en) 1997-11-27
KR100450713B1 (ko) 2004-12-03
CA2256348C (en) 2002-07-23
CN1226338A (zh) 1999-08-18

Similar Documents

Publication Publication Date Title
Brassart et al. Conformational dependence of collagenase (matrix metalloproteinase-1) up-regulation by elastin peptides in cultured fibroblasts
Alam et al. Adjuvant effects and antiserum action potentiation by a (herbal) compound 2-hydroxy-4-methoxy benzoic acid isolated from the root extract of the Indian medicinal plantsarsaparilla'(Hemidesmus indicus R. Br.)
AU708049B2 (en) Method of improving skin condition
EP0457565A2 (en) Milk-protein hydrolyzates and compositions for use as hair and skin treating agent
EP1896497B1 (de) Verfahren zur diagnose von rheumatischen erkrankungen
Heikkinen Transformations of rat skin collagen with special reference to the ageing process
Bass et al. Independent stimulation of motility and the oxidative metabolic burst of human polymorphonuclear leukocytes
Dalmasso et al. Interaction of Autologous Complement with Red Cells in the Absence of Antibody.
Bahnak et al. Effects of alloxan diabetes on the turnover of rat liver glycogen synthase. Comparison with liver phosphorylase.
Choi et al. Effect of platelet lysate on growth and sulfated glycosaminoglycan synthesis in articular chondrocyte cultures
Miyachi et al. Biochemical demonstration and immunohistochemical localization of calpain in human skin
Murphy et al. Erythrocyte microtubule assembly in vitro. Determination of the effects of erythrocyte tau, tubulin isoforms, and tubulin oligomers on erythrocyte tubulin assembly, and comparison with brain microtubule assembly.
Strunk et al. Human peripheral blood monocyte-derived macrophages produce haemolytically active C3 in vitro
Tsai et al. Activation of the complement system by some gram-positive oral bacteria
CN103284929A (zh) 一种护肤品及其制备方法
Riser et al. Gadolinium-induced fibrosis is counter-regulated by CCN3 in human dermal fibroblasts: a model for potential treatment of nephrogenic systemic fibrosis
Scarborough et al. Aggregation of platelets by muscle actin. A multivalent interaction model of platelet aggregation by ADP
JPH06508111A (ja) 甲状腺由来の軟骨細胞刺激因子
CA2135139A1 (en) Topical antibacterial preparation
Schultz et al. Cyanate as an inactivator of complement proteins
Maeland et al. Heterogeneity of antigen from callus of man
Glinski Cellular factors in psoriasis and their interaction with humoral factors
Ohuchi et al. Radiation Fibrosis of Guinea Pig Skin after β Irradiation and an Attempt at Its Suppression with Proline Analogs
Zhang et al. The impact of allergic contact dermatitis on the inflammatory response and repair in wound healing process
Alpers et al. Dog intestinal mucosa contains two vitamin D-stimulated calcium binding proteins